Paul Surdez
Investor Relations Kontakt bei CATALENT, INC.
Profil
Paul Surdez is currently the Vice President-Investor Relations at Catalent, Inc. He previously held the same position at Laboratory Corp.
of America Holdings and Labcorp Drug Development, Inc.
Aktive Positionen von Paul Surdez
Unternehmen | Position | Beginn |
---|---|---|
CATALENT, INC. | Investor Relations Kontakt | 07.01.2020 |
Ehemalige bekannte Positionen von Paul Surdez
Unternehmen | Position | Ende |
---|---|---|
LABCORP HOLDINGS INC. | Investor Relations Kontakt | - |
COVANCE INC. | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CATALENT, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Labcorp Drug Development, Inc.
Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Laboratory Corp. of America Holdings
Laboratory Corp. of America Holdings Services to the Health IndustryHealth Services Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC. | Health Services |